Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
Clinical trial NCT00192374 · COMPLETED
Trial details
- NCT number
- NCT00192374
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Enrollment
- 1920
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.